CoreCap Advisors’s Boston Scientific BSX Stock Holding History

CoreCap Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$103K	Buy	2,349 +37	+2%	+$1.71K	﹤0.01%	1088
2026 Q2	$98.7K	Buy	2,312 +157	+7%	+$8.52K	﹤0.01%	1106
2026 Q1	$135K	Sell	2,155 -491	-19%	-$39.3K	﹤0.01%	928
2025 Q4	$252K	Buy	2,646 +748	+39%	+$73.3K	0.01%	713
2025 Q3	$185K	Sell	1,898 -71	-4%	-$7.35K	0.01%	822
2025 Q2	$211K	Sell	1,969 -21,322	-92%	-$2.16M	0.01%	726
2025 Q1	$2.35M	Sell	23,291 -5,991	-20%	-$603K	0.1%	188
2024 Q4	$2.62M	Buy	29,282 +24,717	+541%	+$2.18M	0.12%	170
2024 Q3	$383K	Buy	+4,565	New	+$360K	0.02%	521
2024 Q2	–	Sell	-3,508	Closed	-$240K	–	1735
2024 Q1	$240K	Buy	+3,508	New	+$226K	0.01%	578
2022 Q4	$81.5K	Buy	+1,762	New	+$76.3K	0.01%	805
2022 Q3	–	Sell	-712	Closed	-$27K	–	734
2022 Q2	$27K	Buy	+712	New	+$29K	﹤0.01%	1134
2022 Q1	–	Sell	-2,362	Closed	-$100K	–	746
2021 Q4	$100K	Buy	+2,362	New	+$99.3K	0.01%	744

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

CoreCap Advisors's BSX Position: Q3 2026 in Review

CoreCap Advisors increased its Boston Scientific (BSX) stake by 1.6% in Q3 2026, buying an estimated $1.71K and bringing the position to 2,349 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

CoreCap Advisors first reported a position in BSX in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.62M in Q4 2024. 306 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

CoreCap Advisors held 2,349 shares of Boston Scientific worth $103K as of Q3 2026.
CoreCap Advisors bought 37 Boston Scientific shares in Q3 2026, an estimated $1.71K.
Boston Scientific made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1088 holding.
CoreCap Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 13 quarters since.
CoreCap Advisors's Boston Scientific position peaked at $2.62M in Q4 2024.
306 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.